Others

Cadila Healthcare Ltd. - USFDA Inspection Ankleshwar Unit I And II

| Updated on July 26, 2019 Published on July 26, 2019

USFDA inspected the Companys API manufacturing facility located at Ankleshwar from 22nd to 26th July, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.

Pdf Link: Cadila Healthcare Ltd. - USFDA Inspection Ankleshwar Unit I And II

Source : BSE - www.bseindia.com

Published on July 26, 2019
This article is closed for comments.
Please Email the Editor